Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 5;13(1):141.
doi: 10.3390/cancers13010141.

Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries

Junjie Huang  1 , Anastasios Koulaouzidis  2 , Wojciech Marlicz  3   4 , Veeleah Lok  5 , Cedric Chu  1 , Chun Ho Ngai  1 , Lin Zhang  6   7   8 , Ping Chen  9 , Shanjuan Wang  10 , Jinqiu Yuan  11 , Xiang-Qian Lao  1 , Shelly L A Tse  1 , Wanghong Xu  12 , Zhi-Jie Zheng  13 , Shao-Hua Xie  14 , Martin C S Wong  1   8   13
Affiliations

Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries

Junjie Huang et al. Cancers (Basel). .

Abstract

This study aimed to examine the global burden, risk factors, and trends of esophageal cancer based on age, sex, and histological subtype. The data were retrieved from cancer registries database from 48 countries in the period 1980-2017. Temporal patterns of incidence and mortality were evaluated by average annual percent change (AAPC) using joinpoint regression. Associations with risk factors were examined by linear regression. The highest incidence of esophageal cancer was observed in Eastern Asia. The highest incidence of adenocarcinoma (AC) was found in the Netherlands, the United Kingdom, and Ireland. A higher AC/squamous cell carcinoma (SCC) incidence ratio was associated with a higher prevalence of obesity and elevated cholesterol. We observed an incidence increase (including AC and SCC) in some countries, with the Czech Republic (female: AAPC 4.66), Spain (female: 3.41), Norway (male: 3.10), Japan (female: 2.18), Thailand (male: 2.17), the Netherlands (male: 2.11; female: 1.88), and Canada (male: 1.51) showing the most significant increase. Countries with increasing mortality included Thailand (male: 5.24), Austria (female: 3.67), Latvia (male: 2.33), and Portugal (male: 1.12). Although the incidence of esophageal cancer showed an overall decreasing trend, an increasing trend was observed in some countries with high AC/SCC incidence ratios. More preventive measures are needed for these countries.

Keywords: esophageal cancer; histological subtypes; incidence; mortality; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The global estimated incidence of esophageal cancer in 2018, both sexes, all ages: (A) male incidence; (B) female incidence. ASR, age-standardized rate. Data source: GLOBOCAN 2018, IARC (http://gco.iarc.fr/today), World Health Organization.
Figure 2
Figure 2
The global estimated mortality of esophageal cancer in 2018, both sexes, all ages: (A) male mortality; (B) female mortality. ASR, age-standardized rate. Data source: GLOBOCAN 2018, IARC (http://gco.iarc.fr/today), World Health Organization.
Figure 3
Figure 3
The risk factors associated with histological subtype ratio of esophageal cancer. These added-variable plots were generated using multi-variable linear regression models. e, residuals; AC, adenocarcinoma; SCC, squamous cell carcinoma; β, β coefficient in the linear regression.
Figure 4
Figure 4
The AAPC of the incidence of esophageal cancer in individuals aged 0–85+ years. AAPC, annual percentage change; * p values less than 0.05; ^ AAPC for these countries could not be generated, as zero or missing values were identified in any year of trend analysis; the 95% confidence intervals and p values for the tests of AAPC are presented in Table S5.
Figure 5
Figure 5
The AAPC of the mortality of esophageal cancer in individuals aged 0–85+ years. AAPC, annual percentage change; * p values less than 0.05; ^ AAPC for these countries could not be generated, as zero or missing values were identified in any year of trend analysis; the 95% confidence intervals and p values for the tests of AAPC are presented in Table S5.
Figure 6
Figure 6
The AAPC of the incidence of esophageal cancer in individuals aged ≥50 years. AAPC, annual percentage change; * p values less than 0.05; ^ AAPC for these countries could not be generated, as zero or missing values were identified in any year of trend analysis; the 95% confidence intervals and p values for the tests of AAPC are presented in Table S5.
See this image and copyright information in PMC

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. American Cancer Society Survival Rates for Esophageal Cancer. [(accessed on 10 June 2020)];2020 Available online: https://www.cancer.org/cancer/esophagus-cancer/detection-diagnosis-stagi....
    1. Shapiro J., van Lanschot J.J.B., Hulshof M., van Hagen P., van Berge Henegouwen M.I., Wijnhoven B.P.L., van Laarhoven H.W.M., Nieuwenhuijzen G.A.P., Hospers G.A.P., Bonenkamp J.J., et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–1098. doi: 10.1016/S1470-2045(15)00040-6. - DOI - PubMed
    1. Al-Batran S.E., Homann N., Pauligk C., Goetze T.O., Meiler J., Kasper S., Kopp H.G., Mayer F., Haag G.M., Luley K., et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): A randomised, phase 2/3 trial. Lancet. 2019;393:1948–1957. doi: 10.1016/s0140-6736(18)32557-1. - DOI - PubMed
    1. Wong M.C.S., Hamilton W., Whiteman D.C., Jiang J.Y., Qiao Y., Fung F.D.H., Wang H.H.X., Chiu P.W.Y., Ng E.K.W., Wu J.C.Y., et al. Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci. Rep. 2018;8:4522. doi: 10.1038/s41598-018-19819-8. - DOI - PMC - PubMed

LinkOut - more resources